SLNO vs. SPY
Compare and contrast key facts about Soleno Therapeutics, Inc. (SLNO) and SPDR S&P 500 ETF (SPY).
SPY is a passively managed fund by State Street that tracks the performance of the S&P 500 Index. It was launched on Jan 22, 1993.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: SLNO or SPY.
Correlation
The correlation between SLNO and SPY is 0.17, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
SLNO vs. SPY - Performance Comparison
Key characteristics
SLNO:
1.17
SPY:
0.51
SLNO:
2.20
SPY:
0.86
SLNO:
1.26
SPY:
1.13
SLNO:
0.87
SPY:
0.55
SLNO:
6.16
SPY:
2.26
SLNO:
13.41%
SPY:
4.55%
SLNO:
70.46%
SPY:
20.08%
SLNO:
-99.86%
SPY:
-55.19%
SLNO:
-88.84%
SPY:
-9.89%
Returns By Period
In the year-to-date period, SLNO achieves a 62.98% return, which is significantly higher than SPY's -5.76% return. Over the past 10 years, SLNO has underperformed SPY with an annualized return of -17.40%, while SPY has yielded a comparatively higher 12.04% annualized return.
SLNO
62.98%
8.71%
33.39%
93.35%
11.18%
-17.40%
SPY
-5.76%
-2.90%
-4.30%
9.72%
15.64%
12.04%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
SLNO vs. SPY — Risk-Adjusted Performance Rank
SLNO
SPY
SLNO vs. SPY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Soleno Therapeutics, Inc. (SLNO) and SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
SLNO vs. SPY - Dividend Comparison
SLNO has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 1.30%.
TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
SLNO Soleno Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SPY SPDR S&P 500 ETF | 1.30% | 1.21% | 1.40% | 1.65% | 1.20% | 1.52% | 1.75% | 2.04% | 1.80% | 2.03% | 2.06% | 1.87% |
Drawdowns
SLNO vs. SPY - Drawdown Comparison
The maximum SLNO drawdown since its inception was -99.86%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for SLNO and SPY. For additional features, visit the drawdowns tool.
Volatility
SLNO vs. SPY - Volatility Comparison
Soleno Therapeutics, Inc. (SLNO) has a higher volatility of 40.11% compared to SPDR S&P 500 ETF (SPY) at 15.12%. This indicates that SLNO's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.